Risk of Ischemic Heart Disease In Patients with TIA
Neurol 34:626-630, Heyman,A.,et al, 1984
Clinicopathological Conference
Case 2-1984, Fabry's Disease, NEJM 310:106-114984., , 1984
Myocardial Damage from Acute Cerebral Lesions
Stroke 15:990-993, Kolin,A.,et al, 1984
Myocardial Infarction & Stroke
Neurol 34:1403-1409, Komrad,M.S.,et al, 1984
Bregmatic Headache as a Manifestation of Myocardial Ischemia
Arch Neurol 39:130, Lefkowitz,D.,et al, 1982
Carotid Endarterectomy:A Prospective Study of Its Efficacy & Safety
Medicine 60:298-309, Allen,G.S.,et al, 1981
Management of Cerebral Embolism of Cardiac Origin
Stroke 11:433-442, Easton,J.D.,et al, 1980
Management of Concomitant, Symptomatic Surgical Lesions of the Coronary & Carotid Arteries
Surg Neurol ll:70-72, Rollinson,R.D.,et al, 1979
Transient Ischemia Attacks:A Prospective Study of 225 Patients
Neurol 28:746-753, Toole,J.F.,et al, 1978
Stroke After Acute Myocardial Infarction:Relation to Infarct Size
BMJ 2:457-459, Thompson,P.L.,et al, 1978
Case Records of the MGH
Metastatic Choreocarcinoma from Ovary, NEJM 296:9261977., , 1977
Electrocardiographic Changes & Myocardial Damage in Patients with Acute Cerebrovascular Accidents
Stroke 8:448, Dimant,J.,et al, 1977
Cardiac Myxoma:A Diagnostic Challenge for the Neurologist
Neurol 26:1060, Yufe,R.,et al, 1976
Shock-Induced Optic Neuropathy A Cause of Nonprogressive Glaucoma
NEJM 288:392, Drance,S.,et al, 1973
Case Record of MGH-NEJM Subdural Hematoma Secondary to Metastasis & Lacunar Infarcts
286:650, , 1972
SLE Case Report-Pathology of the Cardiac Conduction System in SLE
Am J Med 264:255, 1972 Ann Int Med 63:4021965., James,T.,et al, 1965
The Significance of Nonbacterial Thrombotic Endocarditis:An Autopsy & Clinical Study of 78 Cases
Ann Int Med 46:255, MacDonald,R.A.,et al, 1957
Systematic Genetic Assessment in Young Patients with Cryptogenic Stroke: The ES-EASY Project
Stroke 57:148-156, Mania-Paris,L.,et al, 2026
Treatment for Brain Metastases with Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation, A Randomzid Clinical Trial
JAMA doi.10.1001/JAMA.2026.0076;2026, Aizer,A.A.,et al, 2026
A 28-Year-Old Man with Seizures and Thalamic Lesions
Neurol 106:e218065, Santos-Rojo,A.B.,et al, 2026
Melas Syndrome
Stat PearlsPubl Jan 25, Pia,S. & Lui,F., 2025
A 62-Year-Old Man with Progressive Limb Weakness, Involuntary Movements, and HyperCKemia
JAMA Neurol 82L:1286-1287, Liu,Y.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Stroke-Like Migraine Attacks After Radiation Therapy Syndrome
Neurol 104:e210203, Lubotzky,A.,t al, 2025
Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025
A 68-YEar-Old Man with Progressive Numbness, Vertigo, and Cognitive Decline
Neurol 104:e213437, Regan,S.M. & Davalos,L.F., 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025
Myasthenia Gravis - Redemption for B-Cell Depletion
NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025
Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025
Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
Clinicopathologic Conference, Chagas Disease
NEJM 393:1216-1225, Case 27-2025, 2025
New Treatments for Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans
BMJ 390:e085564, Burch, R. & Rittenberg, E., 2025
Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024
Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024
Clinicopathologic Conference, Reversible Cerebral Vasoconstriction Syndrome with Takotsubo Cardiomyopathy
NEJM 390:2108-2118, Case 18-2024, 2024
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024
Cavernous Maliformations of the Central Nervous System
NEJM 390:1022-1028, Smith,E.R., 2024
Extensive Brainstem and Striatal Involvement in Neuropsychiatric Systemic Lupus Erythematosus
Neurol 102:e209153, Branch, A.,et al, 2024
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024
Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024
Clinicopathologic Conference, Systemic Immunoglobulin Light-Chain (AL) Amyloidosis
NEJM 389:166-175, Case 21-2023, 2023
Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023
Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Polymyalgia Rheumatica
Lancet 402:1459-1472, Espigol-Frigole,G.,et al, 2023